Literature DB >> 4786437

Chemotherapy for carcinoma of the bronchus--a brief review.

N M Bleehen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4786437      PMCID： PMC2495815          DOI： 10.1136/pgmj.49.576.723

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  CLINICAL STUDIES OF COMBINED CHEMOTHERAPY AND IRRADIATION IN INOPERABLE BRONCHOGENIC CARCINOMA.

Authors:  F F GOLLIN; F J ANSFIELD; H VERMUND
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1964-07

2.  Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma.

Authors:  H H Hansen; F M Muggia; R Andrews; O S Selawry
Journal:  Cancer       Date:  1972-08       Impact factor: 6.860

3.  Use of chemotherapy as an adjuvant to surgery for bronchogenic carcinoma.

Authors:  G A Higgins
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

4.  Lung cancer: clinical trial of radiotherapy alone vs. radiotherapy plus cyclophosphamide.

Authors:  D E Bergsagel; R D Jenkin; J F Pringle; D M White; J C Fetterly; D J Klaassen; R S McDermot
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

5.  New drugs on the horizon in bronchogenic carcinoma.

Authors:  S K Carter
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

Review 6.  Combination cancer therapy: Presidential address.

Authors:  E Frei
Journal:  Cancer Res       Date:  1972-12       Impact factor: 12.701

7.  Staging of inoperable patients with bronchogenic carcinoma with special reference to bone marrow examination and peritoneoscopy.

Authors:  H H Hansen; F M Muggia
Journal:  Cancer       Date:  1972-11       Impact factor: 6.860

8.  A randomized study of irradiation and vinblastine in lung cancer.

Authors:  P Coy
Journal:  Cancer       Date:  1970-10       Impact factor: 6.860

9.  Alkylating agents in bronchogenic carcinoma.

Authors:  R A Green; E Humphrey; H Close; M E Patno
Journal:  Am J Med       Date:  1969-04       Impact factor: 4.965

10.  Unfavourable effects of long-term adjuvant chemotherapy with Endoxan in radically operated bronchogenic carcinoma.

Authors:  K W Brunner; T Marthaler; W Müller
Journal:  Eur J Cancer       Date:  1971-08       Impact factor: 9.162
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.